Hedge Fund - Newtyn Management
Theravance Biopharma Inc. (TBPH)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $80,453,000 | 8.45% | 4,300,000 | $16.59 |
| 2 | 2025 - Q3 (2025-09-30) | $72,270,000 | 8.85% | 4,950,000 | $12.64 |
| 3 | 2025 - Q2 (2025-06-30) | $54,598,500 | 8.27% | 4,950,000 | $9.72 |
| 4 | 2025 - Q1 (2025-03-31) | $42,483,609 | 6.72% | 4,757,403 | $9.31 |
| 5 | 2024 - Q4 (2024-12-31) | $44,767,162 | 7.79% | 4,757,403 | $9.10 |
| 6 | 2024 - Q3 (2024-09-30) | $36,262,472 | 5.56% | 4,499,066 | $8.66 |
| 7 | 2024 - Q2 (2024-06-30) | $18,017,481 | 3.38% | 2,124,703 | $9.03 |
| 8 | 2024 - Q1 (2024-03-31) | $14,746,052 | 2.93% | 1,643,930 | $9.27 |
| 9 | 2023 - Q4 (2023-12-31) | $21,356,000 | 4.19% | 1,900,000 | $10.06 |
| 10 | 2023 - Q3 (2023-09-30) | $15,892,663 | 3.92% | 1,841,560 | $9.65 |
| 11 | 2023 - Q2 (2023-06-30) | $16,978,720 | 4.01% | 1,640,456 | $11.04 |
| 12 | 2023 - Q1 (2023-03-31) | $16,611,513 | 3.26% | 1,531,015 | $10.57 |
| 13 | 2022 - Q4 (2022-12-31) | $16,269,000 | 3.35% | 1,450,000 | $10.51 |
| 14 | 2022 - Q3 (2022-09-30) | $25,308,000 | 5.55% | 2,495,860 | $9.37 |
| 15 | 2022 - Q2 (2022-06-30) | $18,463,000 | 3.49% | 2,037,825 | $9.21 |
| 16 | 2022 - Q1 (2022-03-31) | $13,145,000 | 3.14% | 1,375,000 | $9.80 |
| 17 | 2021 - Q4 (2021-12-31) | $11,050,000 | 2.93% | 1,000,000 | $8.72 |
| 18 | 2021 - Q3 (2021-09-30) | $725,000 | 0.19% | 97,955 | $11.19 |
| 19 | 2020 - Q1 (2020-03-31) | $0 | 0% | 0 | $25.03 |
| 20 | 2019 - Q4 (2019-12-31) | $4,487,000 | 0.41% | 173,300 | $19.43 |
| 21 | 2019 - Q3 (2019-09-30) | $1,241,000 | 0.11% | 63,681 | $20.20 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center